Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Fluorescent Anti-MUC5AC Brightly Targets Pancreatic Cancer in a Patient-derived Orthotopic Xenograft

MICHAEL A. TURNER, HANNAH M. HOLLANDSWORTH, HIROTO NISHINO, SIAMAK AMIRFAKHRI, THINZAR M. LWIN, ANDREW M. LOWY, SUKHWINDER KAUR, GOPALAKRISHNAN NATARAJAN, KAVITA MALLYA, ROBERT M. HOFFMAN, SURINDER K. BATRA and MICHAEL BOUVET
In Vivo January 2022, 36 (1) 57-62; DOI: https://doi.org/10.21873/invivo.12676
MICHAEL A. TURNER
1Department of Surgery, University of California San Diego, La Jolla, CA, U.S.A.;
2VA San Diego Healthcare System, San Diego, CA, U.S.A.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HANNAH M. HOLLANDSWORTH
1Department of Surgery, University of California San Diego, La Jolla, CA, U.S.A.;
2VA San Diego Healthcare System, San Diego, CA, U.S.A.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROTO NISHINO
1Department of Surgery, University of California San Diego, La Jolla, CA, U.S.A.;
2VA San Diego Healthcare System, San Diego, CA, U.S.A.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SIAMAK AMIRFAKHRI
1Department of Surgery, University of California San Diego, La Jolla, CA, U.S.A.;
2VA San Diego Healthcare System, San Diego, CA, U.S.A.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
THINZAR M. LWIN
1Department of Surgery, University of California San Diego, La Jolla, CA, U.S.A.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANDREW M. LOWY
1Department of Surgery, University of California San Diego, La Jolla, CA, U.S.A.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SUKHWINDER KAUR
3Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, U.S.A.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GOPALAKRISHNAN NATARAJAN
3Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, U.S.A.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAVITA MALLYA
3Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, U.S.A.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ROBERT M. HOFFMAN
1Department of Surgery, University of California San Diego, La Jolla, CA, U.S.A.;
2VA San Diego Healthcare System, San Diego, CA, U.S.A.;
4AntiCancer, Inc., San Diego, CA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SURINDER K. BATRA
3Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, U.S.A.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MICHAEL BOUVET
1Department of Surgery, University of California San Diego, La Jolla, CA, U.S.A.;
2VA San Diego Healthcare System, San Diego, CA, U.S.A.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mbouvet{at}ucsd.edu
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Western blot showing a minimal level of expression of mucin-5AC on the normal pancreas but high levels of expression in a primary patient-derived pancreatic tumor, AA1305, and a patient-derived liver metastasis from a primary pancreatic cancer (PancMet).

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Imaging of subcutaneous models 72 h after injection with 50 μg (A) and 75 μg (B) mucin-5AC monoclonal antibody conjugated to the near-infrared dye IRDye800CW.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Patient-derived orthotopic xenograft (PDOX) model of AA1305 72 h after injection of 75 μg of mucin 5AC (MUC5-AC) monoclonal antibody conjugated to the near-infrared dye IRDye800CW. The implanted pancreatic tumor (black arrow) brightly fluoresced compared to normal pancreas surrounding it (yellow arrow). There is also a fluorescence signal from local tumor invasion on the abdominal wall (white arrow) where the peritoneum overlaid the pancreas, as well as fluorescence on the mouse’s stomach (red arrow). The fluorescence on the stomach does not represent metastatic spread but normal MUC5AC expression, possibly also fluorescence of the mouse chow.

PreviousNext
Back to top

In this issue

In Vivo
Vol. 36, Issue 1
January-February 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Fluorescent Anti-MUC5AC Brightly Targets Pancreatic Cancer in a Patient-derived Orthotopic Xenograft
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Fluorescent Anti-MUC5AC Brightly Targets Pancreatic Cancer in a Patient-derived Orthotopic Xenograft
MICHAEL A. TURNER, HANNAH M. HOLLANDSWORTH, HIROTO NISHINO, SIAMAK AMIRFAKHRI, THINZAR M. LWIN, ANDREW M. LOWY, SUKHWINDER KAUR, GOPALAKRISHNAN NATARAJAN, KAVITA MALLYA, ROBERT M. HOFFMAN, SURINDER K. BATRA, MICHAEL BOUVET
In Vivo Jan 2022, 36 (1) 57-62; DOI: 10.21873/invivo.12676

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Fluorescent Anti-MUC5AC Brightly Targets Pancreatic Cancer in a Patient-derived Orthotopic Xenograft
MICHAEL A. TURNER, HANNAH M. HOLLANDSWORTH, HIROTO NISHINO, SIAMAK AMIRFAKHRI, THINZAR M. LWIN, ANDREW M. LOWY, SUKHWINDER KAUR, GOPALAKRISHNAN NATARAJAN, KAVITA MALLYA, ROBERT M. HOFFMAN, SURINDER K. BATRA, MICHAEL BOUVET
In Vivo Jan 2022, 36 (1) 57-62; DOI: 10.21873/invivo.12676
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Association of TIMP2 Gene Variants With Development of Diabetic Retinopathy
  • PLLA and PDLLA Fillers: Linking Crystallinity and Mechanical Stability to Aggregation, Redispersion, and Collagen Formation
  • IGF-1 Stereotaxic Injection Induces BDNF Expression After Bilateral Common Carotid Artery Occlusion
Show more Experimental Studies

Keywords

  • Pancreatic cancer
  • mucin
  • MUC5AC
  • antibody
  • tumor-specific imaging
  • fluorescence guided surgery
  • PDOX
In Vivo

© 2026 In Vivo

Powered by HighWire